Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer
NCT04225910
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG:
225Ac-PSMA
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine